Clinical Trial Update: GUCY2C Prime-Boost Vaccination for Advanced Colorectal and Small Bowel Adenocarcinomas [Phase 1]

View source ↗

Summary

This entry reports a Phase 1 clinical trial of a GUCY2C prime-boost vaccination for advanced colorectal cancer and small intestinal adenocarcinoma. The study st…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer
• Small Intestinal Adenocarcinoma

Drugs mentioned

• GUCY2C prime-boost vaccination

Snippet

Sponsor: Thomas Jefferson University | Conditions: Colorectal Cancer, Small Bowel Adenocarcinoma | Phase 1 | Status: NOT_YET_RECRUITING